CDMO Recipharm Expands Capabilities in Israel

By Akia Thorpe -

May 15, 2018

Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has partnered with Hadasit Medical Research Services and Development, a subsidiary of Hadassah Medical Organization (HMO) in Jerusalem, Israel, to offer combined clinical, biological, and chemical services.

Hadasit offers a variety of research, development, and consulting services to customers, primarily in the Middle East. With its access to HMO's clinicians and researchers, Hadasit provides clinical-oriented research and development services that can assist from the point of early preclinical development up to regulatory approval.

Recipharm’s facility in Israel has partnered with the firm as part of its growth plans. Recipharm formed operations in Israel in 2015.

Hadasit provides specialist services, including in vitro analysis in various models, access to and analysis of human samples, in vivo models for multiple medical conditions, input regarding medical indications, and the conducting of clinical trials at all phases.

Source: Recipharm